Your browser doesn't support javascript.
loading
Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
Seirafianpour, Farnoosh; Mozafarpoor, Samaneh; Fattahi, Nima; Sadeghzadeh-Bazargan, Afsaneh; Hanifiha, Melika; Goodarzi, Azadeh.
Affiliation
  • Seirafianpour F; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mozafarpoor S; Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Fattahi N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Sadeghzadeh-Bazargan A; Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Hanifiha M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Goodarzi A; Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Dermatol Ther ; 33(4): e13733, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32473070
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Phosphodiesterase Inhibitors / Pneumonia, Viral / Coronavirus Infections Limits: Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2020 Type: Article Affiliation country: Iran
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Phosphodiesterase Inhibitors / Pneumonia, Viral / Coronavirus Infections Limits: Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2020 Type: Article Affiliation country: Iran